USA TODAY via Yahoo
COVID-19 is surging and you can't find a booster? You're not alone.
If the advisory committee at this meeting recommends a pre-summer booster shot for next summer, it could give manufacturers and pharmacies a shot of confidence to make and stock enough doses ...
6 hours ago
The Motley Fool via Yahoo
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
It already has three cancer vaccine candidates in phase 2 clinical trials. I've seen too many cancer vaccines disappoint in late-stage trials to get excited about these programs, but a successful ...
2 days ago
Investing.com
BioNTech shares hold as flu/COVID vaccine trial misses goal By Investing.com
Friday, TD (TSX:TD) Cowen maintained a Hold rating on BioNTech (NASDAQ:BNTX) shares with a price target of $85.00. The decision followed an announcement from Pfizer/BioNTech regarding their ...
4 days ago
The Motley Fool
Why Pfizer Stock Slumped on Friday | The Motley Fool
BioNTech shares hold as BMO keeps $122 target By Investing.com
On Friday, BMO Capital maintained its Outperform rating on BioNTech shares (NASDAQ:BNTX), with a price target of $122.00. The firm's stance comes after BioNTech and its partner Pfizer announced ...
Oppenheimer maintains Perform rating on BioNTech stock By Investing.com
On Friday, Oppenheimer maintained its Perform rating on shares of BioNTech (NASDAQ: NASDAQ:BNTX), following the announcement of Phase 3 trial results for the company's combined mRNA vaccine ...
Zacks
Pfizer (PFE), BioNTech COVID-Flu Combo Shot Study Falters
Pfizer's (PFE) COVID and flu combination vaccine demonstrates a continued trend of higher responses against influenza A but fails to show non-inferiority against the influenza B strain.
Benzinga via Yahoo
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device
7 days ago
Pharma Distribution Giant Cardinal Health Lifts 2025 Guidance After Q4 Earnings Beat, Raises Stock Buyback Expectation By $250M
View all
Biotechnology company from Germany
biontech.com
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Wikipedia
More on Yahoo Finance